Ajooni Biotech Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
95.25 Cr.
|
P/BV
|
1.15
|
Book Value (Rs.)
|
4.82
|
52 Week High/Low (Rs.)
|
10/5
|
FV/ML
|
2/1
|
P/E(X)
|
44.10
|
Bookclosure
|
17/09/2024
|
EPS (Rs.)
|
0.13
|
Div Yield (%)
|
0.00
|
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 2.00 | 2.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 0.25 | 1.94 | 1.05 | 0.37 | 0.41 |
Diluted EPS (Rs.) | 0.25 | 1.94 | 1.05 | 0.37 | 0.41 |
Cash EPS (Rs.) | 0.34 | 0.24 | 2.16 | 0.95 | 0.99 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 4.87 | 4.76 | 16.37 | 15.64 | 18.91 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 4.87 | 4.76 | 16.37 | 15.64 | 18.91 |
Revenue From Operations / Share (Rs.) | 9.14 | 8.50 | 74.00 | 51.01 | 47.63 |
PBDIT / Share (Rs.) | 0.50 | 0.34 | 3.11 | 1.66 | 1.55 |
PBIT / Share (Rs.) | 0.40 | 0.23 | 2.00 | 1.09 | 0.96 |
PBT / Share (Rs.) | 0.34 | 0.17 | 1.46 | 0.50 | 0.57 |
Net Profit / Share (Rs.) | 0.24 | 0.12 | 1.05 | 0.37 | 0.41 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 5.52 | 4.10 | 4.20 | 3.26 | 3.24 |
PBIT Margin (%) | 4.43 | 2.75 | 2.70 | 2.13 | 2.01 |
PBT Margin (%) | 3.73 | 2.11 | 1.97 | 0.98 | 1.20 |
Net Profit Margin (%) | 2.69 | 1.50 | 1.41 | 0.73 | 0.86 |
Return on Networth / Equity (%) | 5.06 | 2.69 | 6.40 | 2.38 | 2.18 |
Return on Capital Employeed (%) | 7.98 | 4.72 | 10.55 | 6.20 | 4.69 |
Return On Assets (%) | 4.54 | 1.91 | 3.61 | 1.33 | 1.50 |
Long Term Debt / Equity (X) | 0.03 | 0.04 | 0.15 | 0.12 | 0.08 |
Total Debt / Equity (X) | 0.05 | 0.12 | 0.32 | 0.43 | 0.31 |
Asset Turnover Ratio (%) | 1.51 | 1.70 | 2.60 | 2.00 | 1.94 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 10.74 | 2.28 | 2.18 | 2.05 | 3.00 |
Quick Ratio (X) | 5.63 | 1.82 | 1.60 | 1.53 | 2.43 |
Inventory Turnover Ratio (X) | 6.25 | 10.27 | 11.35 | 10.01 | 8.36 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 7.95 | 6.40 | 5.76 | 2.85 | 3.97 |
Interest Coverage Ratio (Post Tax) (%) | 4.88 | 3.35 | 2.94 | 1.64 | 2.06 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 53.43 | 39.48 | 72.63 | 36.96 | 11.29 |
EV / Net Operating Revenue (X) | 0.66 | 0.52 | 0.98 | 0.72 | 0.28 |
EV / EBITDA (X) | 12.07 | 12.90 | 23.34 | 22.19 | 8.68 |
MarketCap / Net Operating Revenue (X) | 0.64 | 0.46 | 0.90 | 0.59 | 0.15 |
Price / BV (X) | 1.21 | 0.83 | 4.11 | 1.94 | 0.40 |
Price / Net Operating Revenue (X) | 0.64 | 0.46 | 0.90 | 0.59 | 0.15 |
EarningsYield | 0.04 | 0.03 | 0.01 | 0.01 | 0.05 |